Biological

BCG Solution clinical trials

studies test it: 5
open now: 3
in phase 3: 0
first study started: 2017

Keep track of what changes. Save the BCG Solution studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

BCG Solution: 5
Bacillus Calmette-Guerin Solution: 5
TICE BCG Solution: 5
Bacillus Calmette Guerin Solution: 4

Studies by the year they started

4 studies that test it; most in 2017 (1); 1 more planned to start later

Studies that test BCG Solution, by start year
Year	Studies
2017	1
2021	1
2025	1
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 3
Phase 2: 3
Phase 4: 1

What it is tested for

Each study’s main condition, where its own words name it.

Non-Muscle Invasive Bladder Neoplasms: 3
Carcinoma: 1

Who runs them

Industry 0 · Other 5

Ohio State University Comprehensive Cancer Center (2) · Northwestern University (1) · Fred Hutchinson Cancer Center (1) · Mayo Clinic (1)

Often tested with

Tested in the same studies.

Pembrolizumab (1) · Docetaxel (1) · Gemcitabine (1) · Mitomycin (1)

Studies

Open first, then newest update. How each study uses BCG Solution is read from its arms, and is right about nine times in ten.

Testing it · 5

Given in every arm · 1 — BCG Solution is usual care beside what is tested

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG TherapyRecruitingPhase 3Alliance for Clinical Trials in OncologyNCT07000084Written as BCG Solution

As the comparator · 1 — what is tested is compared with BCG Solution

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder CancerActive, not recruitingPhase 3SWOG Cancer Research NetworkNCT03091660Written as BCG Solution